RBC Capital Maintains Sector Perform on Health Catalyst, Lowers Price Target to $8
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Sean Dodge has maintained a 'Sector Perform' rating on Health Catalyst (NASDAQ:HCAT) but lowered the price target from $13 to $8.
October 30, 2023 | 5:46 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
RBC Capital has maintained its 'Sector Perform' rating on Health Catalyst but lowered the price target from $13 to $8.
The lowering of the price target by RBC Capital indicates a less optimistic outlook for Health Catalyst, which could potentially lead to a decrease in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100